Alzheimer drug doesn’t help chronic fatigue

	Tweet

Treatment with Reminyl (galantamine), a drug used for Alzheimer’s disease, does not improve the symptoms of chronic fatigue syndrome (CFS), new research indicates.

CFS is a debilitating condition of unknown cause. Previous research has shown that Reminyl has certain properties that could be of benefit to people with CFS, according to the report in this week’s Journal of the American Medical Association. With the exception of a small test study, however, the drug has never been tested in such patients. 

To investigate further, Dr. C. V. Russell Blacker, from Wonford House Hospital in Exeter, UK, and colleagues assessed the outcomes of 434 CFS patients who were treated with Reminyl at one of four doses or with an inactive “placebo”.

After 16 weeks of treatment, there was no evidence that Reminyl, at any dose, was better than placebo at improving CFS symptoms.

“To our knowledge, this is the largest completed trial of CFS patients,” the investigators note. The results suggest that Reminyl is not a useful therapy for CFS.

SOURCE: Journal of the American Medical Association, September 8, 2004.

RELATED STORIES:
Brain Surgeon Saves Young Mother from Illness That Nearly Killed His Own Mother   How some brain cells hook up surprises researchers   Staring, sleepiness, other mental lapses more likely in patients with Alzheimer’s   Brain area found to be smaller in cocaine addicts   Brain chemical linked to teen suicides in study   Healthy Diet Could Slow Or Reverse Early Effects of Alzheimer’s Disease   ‘Alert status’ area in brain discoved by Hebrew University scientists   Brain, repair thyself: Studies highlight brain’s resiliency to damage   Childhood music lessons may provide lifelong boost in brain functioning   Study Shows How Social Support May Protect Brain During Stroke   Combining brain imaging, genetic analysis may help identify people at early risk of Alzheimer’s   Contemplative Brain Network Less Complex in Children

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]